Charles River Laboratories International, Inc. News Headlines

CRL 
$57.09
*  
0.53
 negative 
0.92%
Get CRL Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Data on Dynavax' Heplisav - Analyst Blog
9/25/2013 12:00:01 PM - Zacks.com

Encouraging Data on Dapagliflozin - Analyst Blog
9/25/2013 11:17:53 AM - Zacks.com

United Therapeutics NDA Accepted - Analyst Blog
9/13/2013 11:40:01 AM - Zacks.com

Target Date for Endo Health's Aveed - Analyst Blog
9/9/2013 5:57:53 PM - Zacks.com

Good News for Chelsea Therapeutics - Analyst Blog
9/5/2013 4:52:59 PM - Zacks.com

Orexigen Provides Contrave Update - Analyst Blog
8/28/2013 11:10:01 AM - Zacks.com

Update on Chelsea's Northera - Analyst Blog
8/19/2013 11:25:17 AM - Zacks.com

Progenics' Loss Narrows Y/Y - Analyst Blog
8/15/2013 9:31:16 AM - Zacks.com

Salix Misses on 2Q Earnings - Analyst Blog
8/14/2013 11:20:01 AM - Zacks.com

AVEO Pharma Cuts Q2 Loss - Analyst Blog
8/14/2013 9:55:52 AM - Zacks.com

Pharma And Biotechs Offer Rewards And Risk - Which Will You Choose?
8/12/2013 10:04:00 AM - Seeking Alpha

In Line Loss at Orexigen in Q2 - Analyst Blog
8/7/2013 10:41:44 AM - Zacks.com

Label Expansion for Novartis' Menveo - Analyst Blog
8/5/2013 4:40:15 PM - Zacks.com

ABCO Misses Q1 Earnings, Beats Rev - Analyst Blog
8/5/2013 1:40:15 PM - Zacks.com

Charles River Beats on Earnings in Q2 - Analyst Blog
8/1/2013 5:07:50 PM - Zacks.com

Loss Narrows at Dynavax in Q2 - Analyst Blog
7/31/2013 11:21:11 AM - Zacks.com

Good News for BMY/AZN on Dapagliflozin - Analyst Blog
7/29/2013 6:29:01 PM - Zacks.com

Will Merck (MRK) Beat Earnings This Quarter? - Analyst Blog
7/29/2013 3:29:01 PM - Zacks.com

Merck's Vorapaxar NDA Accepted - Analyst Blog
7/25/2013 6:58:09 PM - Zacks.com

Chelsea's NDA for Northera Accepted - Analyst Blog
7/19/2013 5:21:50 PM - Zacks.com

Northera NDA Resubmitted By Chelsea - Analyst Blog
7/11/2013 6:56:18 PM - Zacks.com

Salix Achieves 52-Week High - Analyst Blog
7/9/2013 4:45:01 PM - Zacks.com

Bayer Announces Positive Phase I Data - Analyst Blog
7/8/2013 5:00:01 PM - Zacks.com

Bayer Progresses with its Cancer Drugs - Analyst Blog
7/5/2013 4:30:01 PM - Zacks.com

Yet Another Setback for Bayer/JNJ's Xarelto - Analyst Blog
7/2/2013 5:27:01 PM - Zacks.com